Clinical Trials Browser

Phase 2 × OTHER × Basal Cell Nevus Syndrome × Clear all

NCT00957229 2021-01-11

GDC-0449

Phase 2 Completed

41 enrolled 10 charts

Basal Cell Nevus Syndrome

NCT01556009 2020-11-02

Vismodegib

Phase 2 Completed

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT00489086 2020-10-29

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face

Phase 2 Completed

36 enrolled 7 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Neoplasms

NCT03767439 2019-12-18

Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome

Phase 2 Withdrawn

Basal Cell Nevus Syndrome

NCT02303041 2019-01-29

Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma

Phase 2 Terminated

10 enrolled 11 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Skin Neoplasms

NCT00783965 2016-02-11

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back

Phase 2 Completed

34 enrolled 9 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell